Lymph node micrometastases and outcome of endometrial cancer

Clicks: 431
ID: 116281
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #4 of 14 articles by views in gynecologic oncology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Nodal micrometastases are associated with decreased disease-free survival of patients with endometrial cancer. Adjuvant therapy was associated with improved disease-free survival of patients with micrometastases.
Reference Key
a2019gynecologiclymph Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ignatov A;Lebius C;Ignatov T;Ivros S;Knueppel R;Papathemelis T;Ortmann O;Eggemann H;;
Journal gynecologic oncology
Year 2019
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/31345606
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE chemotherapy humans pubmed abstract nih national institutes of health national library of medicine adult female aged middle aged 80 and over Multicenter Study Retrospective Studies Cohort Studies lymphatic metastasis disease-free survival radiotherapy lymph nodes / pathology* neoplasm micrometastasis germany / epidemiology adjuvant registries pmid:31345606 doi:10.1016/j.ygyno.2019.07.018 atanas ignatov christin lebius holm eggemann endometrial hyperplasia / mortality* endometrial hyperplasia / pathology* endometrial hyperplasia / therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.